Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandan Kumar

Showing results (541-550 of 611) with videos related to

Pageof 62
Sort By:
Biorxiv : the Preprint Server for Biology|November 1, 2024
Somatic Mutations in <i>MCOLN3</i> in Aldosterone-Producing Adenomas cause Primary AldosteronismDesmaré van Rooyen, Sascha Bandulik, Grace Coon, et al.
Cancer Discovery|February 7, 2013
Outlier kinase expression by RNA sequencing as targets for precision therapyVishal Kothari, Iris Wei, Sunita Shankar, et al.
JCO Precision Oncology|December 1, 2025
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition GenesMichelle F Jacobs, Sarah Austin, Andrea M Murad, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancerMichael Overman, Milind Javle, Richard E Davis, et al.
Gastroenterology|March 10, 2015
Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosisChandan Kumar Kedarisetty, Lovkesh Anand, Ankit Bhardwaj, et al.
Plos One|August 14, 2018
Evaluation of cultivated and wild genotypes of Lens species under alkalinity stress and their molecular collocation using microsatellite markersDharmendra Singh, Chandan Kumar Singh, Yash Pal Singh, et al.
Journal of Cancer|May 22, 2014
Predictive simulation approach for designing cancer therapeutic regimens with novel biological mechanismsNicole A Doudican, Amitabha Mazumder, Shweta Kapoor, et al.
JCO Global Oncology|February 13, 2025
Childhood Cancer Survivorship Care in Limited Resource Settings: A Narrative Review and Strategies to Promote Global Health EquityDavid H Noyd, Ana Carolina Izurieta-Pacheco, Rizine Mzikamanda, et al.
Elife|August 4, 2018
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell propertiesEthan V Abel, Masashi Goto, Brian Magnuson, et al.
Cell Reports. Medicine|September 27, 2025
Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastomaRyan James Rebernick, Jae Eun Choi, Calvin Hesse, et al.
Pageof 62

Showing results (541-550 of 611) with videos related to

Sort By:
Pageof 62
Biorxiv : the Preprint Server for Biology|November 1, 2024
Somatic Mutations in <i>MCOLN3</i> in Aldosterone-Producing Adenomas cause Primary AldosteronismDesmaré van Rooyen, Sascha Bandulik, Grace Coon, et al.
Cancer Discovery|February 7, 2013
Outlier kinase expression by RNA sequencing as targets for precision therapyVishal Kothari, Iris Wei, Sunita Shankar, et al.
JCO Precision Oncology|December 1, 2025
Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition GenesMichelle F Jacobs, Sarah Austin, Andrea M Murad, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancerMichael Overman, Milind Javle, Richard E Davis, et al.
Gastroenterology|March 10, 2015
Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosisChandan Kumar Kedarisetty, Lovkesh Anand, Ankit Bhardwaj, et al.
Plos One|August 14, 2018
Evaluation of cultivated and wild genotypes of Lens species under alkalinity stress and their molecular collocation using microsatellite markersDharmendra Singh, Chandan Kumar Singh, Yash Pal Singh, et al.
Journal of Cancer|May 22, 2014
Predictive simulation approach for designing cancer therapeutic regimens with novel biological mechanismsNicole A Doudican, Amitabha Mazumder, Shweta Kapoor, et al.
JCO Global Oncology|February 13, 2025
Childhood Cancer Survivorship Care in Limited Resource Settings: A Narrative Review and Strategies to Promote Global Health EquityDavid H Noyd, Ana Carolina Izurieta-Pacheco, Rizine Mzikamanda, et al.
Elife|August 4, 2018
HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell propertiesEthan V Abel, Masashi Goto, Brian Magnuson, et al.
Cell Reports. Medicine|September 27, 2025
Chromosomal instability degrades developmental phenotypes essential for anti-GD2 immunotherapy outcomes in high-risk neuroblastomaRyan James Rebernick, Jae Eun Choi, Calvin Hesse, et al.
Pageof 62